Experts
Stories by Tim Boreham
Experts
CRITERION: Psst. Wanna buy a stock powered completely by mobile phone addicted idiots?
Health & Biotech
Health Kick Podcast: Prescient Therapeutics’ PTX-100 continues to show encouraging results following FDA Orphan Drug Designation
Health & Biotech
Dr Boreham’s Crucible: Every sperm is sacred – and profitable
Health & Biotech
Health Kick Podcast: EZZ signs agreement with University of Auckland to conduct product research
Experts
CRITERION: Going for gold? Maybe try to beat the big boys to these takeover targets
Experts
CRITERION: In a wounded tech sector, these 10 stocks are tipped for a profitable year ahead
Experts
Dr Boreham’s Crucible: Neuren conquers the FDA; next stop, the world?
Experts
CRITERION: The ASX takeover targets whose furious paddling is attracting all the sharks
Health & Biotech
Dr Boreham’s Crucible: Tag it and bag it – Bluechiip’s ready to come in from the cold
Experts
CRITERION: Are recession-hit Aussies willing to punt their kids for ASX gambling stocks?
Experts